Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference The new mini-textbook by Kamps & Hoffmann PDF, 110 pages

Breast Cancer

Free Subscription 02.03.2020 1 Am J Surg 6 Ann Oncol 1 Ann Surg 1 Ann Surg Oncol 4 BMC Cancer 4 Breast Cancer 2 Breast Cancer (Dove Med Press) 3 Breast Cancer Res 4 Breast Cancer Res Treat 2 Breast J 2 Cancer 1 Clin Breast Cancer 1 Clin Cancer Res 1 Eur J Surg Oncol 1 Gene 1 Int J Cancer 3 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 4 J Natl Cancer Inst 1 J Surg Oncol 2 JAMA 1 N Engl J Med 1 Oncogene 1 Oncol Rep 2 Pathology 1 PLoS One 2 Pol J Radiol 2 Radiology 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. NAYYAR A, Strassle PD, Reddy KG, Jameison DI, et al
   Variations in the utilization of immediate post-mastectomy breast reconstruction.
   Am J Surg. 2019;218:712-715.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. KIM H, Son S
   Therapeutic potential of connective tissue growth factor (CTGF) in triple-negative breast cancer.
   Ann Oncol. 2019;30 Suppl 1:i8.
   PubMed     Text format    
   
   
3. YAP YS, Ho D, Ng RC, Chan CH, et al
   Detection of genomic alterations in breast cancer (BC) patients with paired plasma and tumour specimens.
   Ann Oncol. 2019;30 Suppl 1:i10.
   PubMed     Text format    
   
   
4. PARK YH, Senkus-Konefka E, Im SA, Pentheroudakis G, et al
   Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
   Ann Oncol. 2020 Jan 16. pii: S0923-7534(20)35929.
   PubMed     Text format     Abstract available
   
   
5. SON S, Kim H, Shin I
   Matricellular protein CCN3/NOV regulates tumorigenesis in triple-negative breast cancer.
   Ann Oncol. 2019;30 Suppl 1:i8.
   PubMed     Text format    
   
   
6. GRYNBERG M, Mayeur Le Bras A, Hesters L, Gallot V, et al
   First birth achieved after fertility preservation using vitrification of in vitro matured oocytes in a woman with breast cancer.
   Ann Oncol. 2020 Feb 12. pii: S0923-7534(20)35923.
   PubMed     Text format    
   
   
7. BJELIC-RADISIC V, Cardoso F, Cameron D, Brain E, et al
   Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288.
   Ann Oncol. 2020 Feb 20. pii: S0923-7534(20)36026.
   PubMed     Text format    
   
   

   
   Ann Surg

8. RANGANATHAN K, Singh P, Raghavendran K, Wilkins EG, et al
   The Global Macroeconomic Burden of Breast Cancer: Implications for Oncologic Surgery.
   Ann Surg. 2020 Feb 12. doi: 10.1097/SLA.0000000000003662.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

9. LAWS A, Xu Y, Kong S, Brisson AM, et al
   Breast Biopsy During Post-treatment Surveillance of Screen-Detected Breast Cancer Patients Yields High Rates of Benign Findings.
   Ann Surg Oncol. 2020 Feb 25. pii: 10.1245/s10434-020-08259.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

10. LI L, Zhang H, Wang L, Xie C, et al
    A retrospective analysis on metastatic rate of the internal mammary lymph node and its clinical significance in adjuvant radiotherapy of breast cancer patients.
    BMC Cancer. 2020;20:153.
    PubMed     Text format     Abstract available
    
    
11. DE HAAN R, van Werkhoven E, van den Heuvel MM, Peulen HMU, et al
    Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib.
    BMC Cancer. 2019;19:901.
    PubMed     Text format     Abstract available
    
    
12. KALECKY K, Modisette R, Pena S, Cho YR, et al
    Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal-like 2 TNBC subtypes.
    BMC Cancer. 2020;20:141.
    PubMed     Text format     Abstract available
    
    
13. OBA T, Maeno K, Takekoshi D, Ono M, et al
    Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer.
    BMC Cancer. 2020;20:160.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer

14. SEMAAN J, El-Hakim S, Ibrahim JN, Safi R, et al
    Comparative effect of sodium butyrate and sodium propionate on proliferation, cell cycle and apoptosis in human breast cancer cells MCF-7.
    Breast Cancer. 2020 Feb 24. pii: 10.1007/s12282-020-01063.
    PubMed     Text format     Abstract available
    
    
15. MYOJIN M, Horimoto Y, Ito M, Kitano S, et al
    Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer.
    Breast Cancer. 2020 Feb 27. pii: 10.1007/s12282-020-01069.
    PubMed     Text format     Abstract available
    
    
16. OHISHI Y, Mitsuda A, Ejima K, Morizono H, et al
    Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient.
    Breast Cancer. 2020 Feb 24. pii: 10.1007/s12282-020-01064.
    PubMed     Text format     Abstract available
    
    
17. JYLLING AMB, Jensen V, Lelkaitis G, Christiansen P, et al
    Male breast cancer: clinicopathological characterization of a National Danish cohort 1980-2009.
    Breast Cancer. 2020 Feb 27. pii: 10.1007/s12282-020-01066.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

18. JAHANI SAYAD NOVEIRI M, Shamsaei F, Khodaveisi M, Vanaki Z, et al
    Coping Assessment Tools in the Family Caregivers of Patients with Breast Cancer: A Systematic Review.
    Breast Cancer (Dove Med Press). 2020;12:11-26.
    PubMed     Text format     Abstract available
    
    
19. MINA LA, Lim S, Bahadur SW, Firoz AT, et al
    Immunotherapy for the Treatment of Breast Cancer: Emerging New Data.
    Breast Cancer (Dove Med Press). 2019;11:321-328.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res

20. GRANT WB
    Lower vitamin D status may help explain why black women have a higher risk of invasive breast cancer than white women.
    Breast Cancer Res. 2020;22:24.
    PubMed     Text format    
    
    
21. MAVADDAT N, Antoniou AC, Mooij TM, Hooning MJ, et al
    Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
    Breast Cancer Res. 2020;22:25.
    PubMed     Text format     Abstract available
    
    
22. BATALINI F, Peacock EG, Stobie L, Robertson A, et al
    Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
    Breast Cancer Res. 2019;21:107.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

23. JEON YW, Bang HW, Suh YJ, Kim G, et al
    The long-term effect of age on cardiovascular disease in patients with breast cancer who received chemotherapy.
    Breast Cancer Res Treat. 2020 Feb 25. pii: 10.1007/s10549-020-05568.
    PubMed     Text format     Abstract available
    
    
24. PARACHA N, Reyes A, Dieras V, Krop I, et al
    Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analys
    Breast Cancer Res Treat. 2020 Feb 25. pii: 10.1007/s10549-020-05577.
    PubMed     Text format     Abstract available
    
    
25. ROJAS-LIMA E, Gamboa-Loira B, Cebrian ME, Rothenberg SJ, et al
    A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women.
    Breast Cancer Res Treat. 2020 Feb 22. pii: 10.1007/s10549-020-05562.
    PubMed     Text format     Abstract available
    
    
26. LAMBERT-COTE L, Bouhnik AD, Bendiane MK, Berenger C, et al
    Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases.
    Breast Cancer Res Treat. 2020 Feb 21. pii: 10.1007/s10549-020-05549.
    PubMed     Text format     Abstract available
    
    

    
    Breast J

27. BOLAND MR, Heneghan HM, Ryan EJ, Ain Q, et al
    A systematic review and meta-analysis of the utility of lymphoscintigraphy in the management of clinically node-negative breast cancer.
    Breast J. 2020 Feb 24. doi: 10.1111/tbj.13791.
    PubMed     Text format    
    
    
28. BEN KRIDIS W, Werda I, Mnejja W, Daoud J, et al
    Hormone resistance and breast cancer in young women: Correlated factors and survival impact.
    Breast J. 2020 Feb 26. doi: 10.1111/tbj.13795.
    PubMed     Text format    
    
    

    
    Cancer

29. AVIS NE, Levine B, Goyal N, Crawford SL, et al
    Health-related quality of life among breast cancer survivors and noncancer controls over 10 years: Pink SWAN.
    Cancer. 2020 Feb 27. doi: 10.1002/cncr.32757.
    PubMed     Text format     Abstract available
    
    
30. PETERSON LL, Park S, Park Y, Colditz GA, et al
    Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study.
    Cancer. 2020 Feb 25. doi: 10.1002/cncr.32798.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

31. KIM KN, Qureshi MM, Huang D, Ko NY, et al
    The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis.
    Clin Breast Cancer. 2020 Jan 14. pii: S1526-8209(19)30769.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

32. INGLE JN, Cairns J, Suman VJ, Shepherd LE, et al
    Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor alpha.
    Clin Cancer Res. 2020 Feb 25. pii: 1078-0432.CCR-19-3091.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

33. SUNDEN M, Hermansson C, Taflin H, Andersson A, et al
    Surgical treatment of breast cancer liver metastases - A nationwide registry-based case control study.
    Eur J Surg Oncol. 2020 Feb 15. pii: S0748-7983(20)30110.
    PubMed     Text format     Abstract available
    
    

    
    Gene

34. DOULABI MSH, Ghaedi K, Ranji N, Koohpar ZK, et al
    rs1016860 of BCL2 3'UTR associates with hsa-miR-629-5p binding potential in breast cancer and gastric cancer in isfahan population.
    Gene. 2020 Feb 17:144457. doi: 10.1016/j.gene.2020.144457.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

35. FARES J, Kanojia D, Rashidi A, Ulasov I, et al
    Landscape of Combination Therapy Trials in Breast Cancer Brain Metastasis.
    Int J Cancer. 2020 Feb 22. doi: 10.1002/ijc.32937.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

36. SCHLOSSER S, Rabinovitch R, Shatz Z, Galper S, et al
    Radiation Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Feb 18. pii: S0360-3016(20)30219.
    PubMed     Text format     Abstract available
    
    
37. KENNEDY WR, Thomas MA, Stanley JA, Luo J, et al
    Single Institution Phase I/II Prospective Clinical Trial of Single Fraction High Gradient Adjuvant Partial Breast Irradiation for Hormone Sensitive Stage 0-I Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Feb 18. pii: S0360-3016(20)30220.
    PubMed     Text format     Abstract available
    
    
38. SPERDUTO PW, Mesko S, Li J, Cagney D, et al
    Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases from 1985 to Today.
    Int J Radiat Oncol Biol Phys. 2020 Feb 18. pii: S0360-3016(20)30205.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

39. DELALOGE S, Piccart M, Rutgers E, Litiere S, et al
    Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.
    J Clin Oncol. 2020 Feb 21:JCO1901371. doi: 10.1200/JCO.19.01371.
    PubMed     Text format     Abstract available
    
    
40. TUNG N, Arun B, Hacker MR, Hofstatter E, et al
    TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial).
    J Clin Oncol. 2020 Feb 25:JCO1903292. doi: 10.1200/JCO.19.03292.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

41. YANG X, Song H, Leslie G, Engel C, et al
    Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D.
    J Natl Cancer Inst. 2020 Feb 28. pii: 5764125. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
42. TERAS LR, Patel AV, Smith-Warner SA
    Re: Sustained weight loss and risk of breast cancer in women >/=50 years - Authors' Reply.
    J Natl Cancer Inst. 2020 Feb 26. pii: 5758264. doi: 10.1093.
    PubMed     Text format    
    
    
43. FLEGAL KM
    Re: Sustained weight loss and risk of breast cancer in women >/=50 years: a pooled analysis of prospective data.
    J Natl Cancer Inst. 2020 Feb 26. pii: 5758265. doi: 10.1093.
    PubMed     Text format    
    
    
44. HU C, Polley EC, Yadav S, Lilyquist J, et al
    The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort.
    J Natl Cancer Inst. 2020 Feb 24. pii: 5753953. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

45. JIANG L, Liu T, Wang X, Li J, et al
    Real-time near-infrared fluorescence imaging mediated by blue dye in breast cancer patients.
    J Surg Oncol. 2020 Feb 26. doi: 10.1002/jso.25874.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

46. COMSTOCK CE, Gatsonis C, Newstead GM, Snyder BS, et al
    Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    JAMA. 2020;323:746-756.
    PubMed     Text format     Abstract available
    
    
47. TOSTESON ANA
    An Abbreviated MRI Protocol for Breast Cancer Screening in Women With Dense Breasts: Promising Results, but Further Evaluation Required Prior to Widespread Implementation.
    JAMA. 2020;323:719-721.
    PubMed     Text format    
    
    

    
    N Engl J Med

48. SCHMID P, Cortes J, Pusztai L, McArthur H, et al
    Pembrolizumab for Early Triple-Negative Breast Cancer.
    N Engl J Med. 2020;382:810-821.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

49. YOE J, Kim D, Kim S, Lee Y, et al
    Capicua restricts cancer stem cell-like properties in breast cancer cells.
    Oncogene. 2020 Feb 27. pii: 10.1038/s41388-020-1230.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

50. TRIVIZAKIS E, Ioannidis GS, Melissianos VD, Papadakis GZ, et al
    A novel deep learning architecture outperforming 'offtheshelf' transfer learning and featurebased methods in the automated assessment of mammographic breast density.
    Oncol Rep. 2019;42:2009-2015.
    PubMed     Text format     Abstract available
    
    

    
    Pathology

51. RHODES A, Teoh KH, See MH, Ganesan K, et al
    Breast cancer hormone receptor testing in Asia: is it time to think again on expected positivity rates and methods of scoring?
    Pathology. 2020 Feb 24. pii: S0031-3025(20)30709.
    PubMed     Text format    
    
    
52. XU Z, Shen W, Pan A, Sun F, et al
    Decreased Nek9 expression correlates with aggressive behaviour and predicts unfavourable prognosis in breast cancer.
    Pathology. 2020 Feb 22. pii: S0031-3025(20)30458.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

53. LEE S, Liang X, Woods M, Reiner AS, et al
    Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study.
    PLoS One. 2020;15:e0226157.
    PubMed     Text format     Abstract available
    
    

    
    Pol J Radiol

54. GEMICI AA, Inci E
    Agreement between dynamic contrast-enhanced magnetic resonance imaging and pathologic tumour size of breast cancer and analysis of the correlation with BI-RADS descriptors.
    Pol J Radiol. 2019;84:e616-e624.
    PubMed     Text format     Abstract available
    
    
55. BAYOUMI D, Zaky M, Ibrahim DA, Abdallah A, et al
    The additive role of (1)H-magnetic resonance spectroscopic imaging to ensure pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Pol J Radiol. 2019;84:e570-e580.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

56. LEE CI, Lee JM
    Identifying Effective Supplemental Screening Strategies for Women with a Personal History of Breast Cancer.
    Radiology. 2020 Feb 25:200015. doi: 10.1148/radiol.2020200015.
    PubMed     Text format    
    
    
57. KIM SY, Cho N, Kim SY, Choi Y, et al
    Supplemental Breast US Screening in Women with a Personal History of Breast Cancer: A Matched Cohort Study.
    Radiology. 2020 Feb 25:191691. doi: 10.1148/radiol.2020191691.
    PubMed     Text format     Abstract available
    
    

    
    Radiother Oncol

58. GULTEKIN M, Tilki B, Yildiz F
    In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
    Radiother Oncol. 2020 Feb 18. pii: S0167-8140(20)30027.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: